5 Oct 2026, 08:20
Meetings & Governance—
ALAAROVELLA THERAPEUTICS LIMITED
Announcement history available from 1 August 2025
Fromto
1 Oct 2026, 13:54
Company UpdateMS
17 Sept 2026, 08:56
Periodic Reports—
9 Sept 2026, 08:21
Meetings & Governance—
7 Sept 2026, 09:00
Company UpdateMS
20 Aug 2026, 11:31
Company Administration—
20 Aug 2026, 11:28
Company Administration—
20 Aug 2026, 11:27
Financial ResultsMS
17 Aug 2026, 11:59
Securities Administration—
12 Aug 2026, 13:11
Presentations—
11 Aug 2026, 16:10
Presentations—
27 July 2026, 12:15
Quarterly ReportsMS
30 June 2026, 09:12
Securities Administration—
30 June 2026, 09:08
Securities Administration—
30 June 2026, 09:06
Securities Administration—
25 June 2026, 08:19
Company Update—
10 June 2026, 09:09
Director Interests—
9 June 2026, 14:01
Company Administration—
26 May 2026, 09:26
Securities Administration—
8 May 2026, 08:33
Securities Administration—
7 May 2026, 10:20
Director Interests—
7 May 2026, 08:30
Company Update—
7 May 2026, 08:24
Company AdministrationMS
4 May 2026, 10:00
Company AdministrationMS
1 May 2026, 10:22
Director Interests—
28 Apr 2026, 15:58
Company Administration—
28 Apr 2026, 15:51
Quarterly ReportsMS
27 Apr 2026, 08:54
Securities Administration—
23 Apr 2026, 08:30
Meetings & Governance—
23 Apr 2026, 08:21
Securities Administration—
22 Apr 2026, 11:05
Company Administration—
20 Apr 2026, 10:01
Company Update—
15 Apr 2026, 08:26
Periodic Reports—
13 Apr 2026, 08:28
Securities Administration—
10 Apr 2026, 14:21
Securities Administration—
10 Apr 2026, 14:20
Securities Administration—
10 Apr 2026, 14:19
Company Administration—
1 Apr 2026, 09:54
Company UpdateMS
16 Mar 2026, 10:27
Company Update—
19 Feb 2026, 14:57
Financial ResultsMS
19 Feb 2026, 08:30
Securities Administration—
19 Feb 2026, 08:25
Securities Administration—
19 Feb 2026, 08:24
Securities Administration—
16 Feb 2026, 08:25
Securities Administration—
16 Feb 2026, 08:23
Securities Administration—
16 Feb 2026, 08:21
Securities Administration—
13 Feb 2026, 09:41
Securities Administration—
13 Feb 2026, 09:40
Securities Administration—
9 Feb 2026, 13:58
Director Interests—
9 Feb 2026, 10:00
Company Administration—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 5 Oct 2026, 08:20 | Notice of Annual General Meeting/Proxy Form | Meetings & Governance | — | 08004, 08006 | |
| 1 Oct 2026, 13:54 | The path to first patient dosing | Company Update | MS | 11001 | |
| 17 Sept 2026, 08:56 | 2026 ESG Report | Periodic Reports | — | 03014, 12008 | |
| 9 Sept 2026, 08:21 | Notification of 2026 AGM Date | Meetings & Governance | — | 08006, 16002 | |
| 7 Sept 2026, 09:00 | Clinical manufacturing batch released, first site activated | Company Update | MS | 11001 | |
| 20 Aug 2026, 11:31 | Corporate Governance Statement | Company Administration | — | 03024 | |
| 20 Aug 2026, 11:28 | Appendix 4G | Company Administration | — | 03025 | |
| 20 Aug 2026, 11:27 | Appendix 4E and Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 17 Aug 2026, 11:59 | Notification regarding unquoted securities - ALA | Securities Administration | — | 06021 | |
| 12 Aug 2026, 13:11 | Investor Webinar Presentation | Presentations | — | 03026, 14014 | |
| 11 Aug 2026, 16:10 | Investor Webinar Registration | Presentations | — | 14014 | |
| 27 July 2026, 12:15 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19004, 19009 | |
| 30 June 2026, 09:12 | Notice under Section 708A | Securities Administration | — | 06018 | |
| 30 June 2026, 09:08 | Notification of cessation of securities - ALA | Securities Administration | — | 06027 | |
| 30 June 2026, 09:06 | Application for quotation of securities - ALA | Securities Administration | — | 06020 | |
| 25 June 2026, 08:19 | First-In-Human Trial | Company Update | — | 11001 | |
| 10 June 2026, 09:09 | Change of Director's Interest Notice | Director Interests | — | 02009 | |
| 9 June 2026, 14:01 | Turtle to Clinical Advisory Board&Fiorenza Lead Investigator | Company Administration | — | 12008 | |
| 26 May 2026, 09:26 | Notification of cessation of securities - ALA | Securities Administration | — | 06027 | |
| 8 May 2026, 08:33 | Notification of cessation of securities - ALA | Securities Administration | — | 06027 | |
| 7 May 2026, 10:20 | Final Director's Interest Notice x4 | Director Interests | — | 02010 | |
| 7 May 2026, 08:30 | Arovella Presents at ISCT Conference in Dublin | Company Update | — | 11001 | |
| 7 May 2026, 08:24 | Arovella Appoints Acting CEO | Company Administration | MS | 12019 | |
| 4 May 2026, 10:00 | Board Refresh and CEO Resignation | Company Administration | MS | 12001, 12017, 12019 | |
| 1 May 2026, 10:22 | Initial Director's Interest Notice x4 | Director Interests | — | 02008 | |
| 28 Apr 2026, 15:58 | Appointment of 4x Non-Executive Directors | Company Administration | — | 12001 | |
| 28 Apr 2026, 15:51 | Quarterly Activities/Appendix 4C Cash Flow Report | Quarterly Reports | MS | 19003, 19008 | |
| 27 Apr 2026, 08:54 | Notification regarding unquoted securities - ALA | Securities Administration | — | 06021 | |
| 23 Apr 2026, 08:30 | Notice Received Under Section 249D Withdrawn | Meetings & Governance | — | 08006, 12008 | |
| 23 Apr 2026, 08:21 | Proposed issue of securities - ALA | Securities Administration | — | 06013 | |
| 22 Apr 2026, 11:05 | Update Regarding Section 249D Notice | Company Administration | — | 12008 | |
| 20 Apr 2026, 10:01 | Arovella Presents Poster at AACR Annual Meeting | Company Update | — | 11001 | |
| 15 Apr 2026, 08:26 | ALA Receives Additional R&D Tax Rebate of $0.28 Million | Periodic Reports | — | 03014, 12008 | |
| 13 Apr 2026, 08:28 | Notification of cessation of securities - ALA | Securities Administration | — | 06027 | |
| 10 Apr 2026, 14:21 | Application for quotation of securities - ALA | Securities Administration | — | 06020 | |
| 10 Apr 2026, 14:20 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 10 Apr 2026, 14:19 | Notice received under section 249D of the Corporations Act | Company Administration | — | 12008 | |
| 1 Apr 2026, 09:54 | CLDN18.2 CAR iNKT Cell Preclinical Data Update | Company Update | MS | 11001 | |
| 16 Mar 2026, 10:27 | TGA Clears ALA-101 Trial Under CTN Scheme | Company Update | — | 11001 | |
| 19 Feb 2026, 14:57 | Half Year Report and Appendix 4D | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 19 Feb 2026, 08:30 | 20260219 ALA 708A Cleansing Notice | Securities Administration | — | 06018 | |
| 19 Feb 2026, 08:25 | Notification of cessation of securities - ALA | Securities Administration | — | 06027 | |
| 19 Feb 2026, 08:24 | Application for quotation of securities - ALA | Securities Administration | — | 06020 | |
| 16 Feb 2026, 08:25 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 16 Feb 2026, 08:23 | Application for quotation of securities - ALA | Securities Administration | — | 06020 | |
| 16 Feb 2026, 08:21 | Notification of cessation of securities - ALA | Securities Administration | — | 06027 | |
| 13 Feb 2026, 09:41 | Notice Under Section 708A | Securities Administration | — | 06018 | |
| 13 Feb 2026, 09:40 | Application for quotation of securities - ALA | Securities Administration | — | 06020 | |
| 9 Feb 2026, 13:58 | Final Director's Interest Notice x2 | Director Interests | — | 02010 | |
| 9 Feb 2026, 10:00 | Board Changes | Company Administration | — | 12001, 12017 |
1–50 of 104
1 / 3